《单纯疱疹病毒2感染可能提高男性和女性HIV感染几率:纵向研究的系统评价和meta分析》

  • 来源专题:艾滋病防治
  • 编译者: 李越
  • 发布时间:2007-04-27
  • Objective: To estimate the sex-specific effect of herpes simplex virus type 2 (HSV-2) on the acquisition of HIV infection. Background: The increased number of longitudinal studies available since the last meta-analysis was published allows for the calculation of age- and sexual behaviour-adjusted relative risks (RR) separately for men and women. Design: Systematic review and meta-analysis of longitudinal studies. Methods: PubMed, Embase and relevant conference abstracts were systematically searched to identify longitudinal studies in which the relative timing of HSV-2 infection and HIV infection could be established. Where necessary, authors were contacted for separate estimates in men and women, adjusted for age and a measure of sexual behaviour. Summary adjusted RR were calculated using random-effects meta-analyses where appropriate. Studies on recent HSV-2 incidence as a risk factor for HIV acquisition were also collated. Results: Of 19 eligible studies identified, 18 adjusted for age and at least one measure of sexual behaviour after author contact. Among these, HSV-2 seropositivity was a statistically significant risk factor for HIV acquisition in general population studies of men [summary adjusted RR, 2.7; 95% confidence interval (CI), 1.9-3.9] and women (RR, 3.1; 95% CI, 1.7-5.6), and among men who have sex with men (RR, 1.7; 95% CI, 1.2-2.4). The effect in high-risk women showed significant heterogeneity, with no overall evidence of an association. Conclusions: Prevalent HSV-2 infection is associated with a three-fold increased risk of HIV acquisition among both men and women in the general population, suggesting that, in areas of high HSV-2 prevalence, a high proportion of HIV is attributable to HSV-2.
  • 原文来源:http://www.aidsonline.com/pt/re/aids/pdfhandler.00002030-200601020-00011.pdf;jsessionid=GxHG5dVQvBJdhlTzZ2qPBLZwQYfQyPmhynNR0FLngxb0Tk1Jxx6Q!-1905490407!-949856144!8091!-1
相关报告
  • 《实现持续病毒学应答后的复发和再感染丙肝病毒的风险:系统评价和Meta分析》

    • 来源专题:病毒性肝炎防治
    • 编译者:肖宇锋
    • 发布时间:2016-03-03
    • 对丙肝病毒的治疗可使90%患者获得持续性病毒学应答(SVR)。无论是丙肝的复发还是再感染,都对SVR有部里影响。伦敦帝国学院的研究者对HCV复发后的SVR进行了研究。使用随访的事件/人年来计算各研究中的复发率。将病人分为三组:1.单纯感染HCV的低风险患者;2.单纯感染HCV的高风险患者(注射毒品者或囚犯);3.合并感染HIV和HCV的患者。结果是,低风险患者的复发率为1.85/1000,五年复发率为95%;高风险患者22.32/1000,5年复发率为10.67%;HIV/HCV合并感染者的复发率为32.02/1000,5年复发率为15.02%。高风险患者和合并感染患者组复发率较高是由于再次感染几率高。
  • 《2019新冠病毒(COVID-19)感染合并症的患病率:一项系统评价和Meta分析》

    • 来源专题:新发突发疾病(新型冠状病毒肺炎)
    • 编译者:蒋君
    • 发布时间:2020-04-04
    • 在中国武汉爆发的2019新型冠状病毒(COVID -19)疫情比最初估计的更为广泛,目前多个国家均有确诊。该系统评价的目的是评估COVID-19感染患者的合并症患病率以及重症患者与非重症患者相比的潜在疾病风险。使用PubMed,EMBASE和Web of sciences数据库进行文献检索,文献截止到2020年2月25日。使用随机效应模型汇总风险比(OR)和95%置信区间(CI)。研究共纳入八项研究,包括了46248名感染者。结果显示,最常见的临床症状是发烧(91±3,95%CI 86-97%),其次是咳嗽(67±7,95%CI 59-76%),乏力(51±0,95%CI) 34-68%)和呼吸困难(30±4,95%CI 21-40%)。最常见的合并症是高血压(17±7,95%CI 14-22%)和糖尿病(8±6,95%CI 6-11%),其次是心血管疾病(5±4,95%CI 4-7 %)和呼吸系统疾病(2±0,95%CI 1-3%)。与非重症患者相比,重症患者的高血压,呼吸系统疾病和心血管疾病的患病风险比值比分别为(OR 2.36,95%CI:1.46-3.83),(OR 2.46,95%CI:1.76-3.44)和(OR 3.42,95%CI:1.88-6.22)。研究评估了COVID-19感染者的合并症患病率,发现与非重症患者相比,重症患者的潜在疾病危险因素包括高血压,呼吸系统疾病和心血管疾病等。